Fibroblast growth factor 21, dislipidemia in patients with coronary artery disease and concomitant obesity
Loading...
Date
Author(s)
Editor(s)
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Recent studies have revealed that fibroblast growth
factor 21 (FGF21) plays important role in energy metabolism
regulation. FGF21 contributes to many age-related
metabolic disorders, e.g. atherosclerosis, obesity, type 2
diabetes, and some cardiovascular diseases
Description
Citation
Ivanova K. V. Fibroblast growth factor 21, dislipidemia in patients with coronary artery disease and concomitant obesity / K. V. Ivanova // Український кардіологічний журнал. – 2018. – Додаток 1 : ХІХ Національний конгрес кардіологів України: тези доповідей, Київ, 26–28 вересня 2018. – С. 56.